These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 25630630)

  • 1. Current trends in tauopathy research: from disease modelling to therapeutic approaches.
    Frank S; Tolnay M
    Neuropathol Appl Neurobiol; 2015 Feb; 41(1):1-2. PubMed ID: 25630630
    [No Abstract]   [Full Text] [Related]  

  • 2. Tauopathy models and human neuropathology: similarities and differences.
    Frank S; Clavaguera F; Tolnay M
    Acta Neuropathol; 2008 Jan; 115(1):39-53. PubMed ID: 17786456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introduction to the special issue of brain structure and function on transgenic modeling of neurodegenerative disorders.
    Hof PR; Elder GA
    Brain Struct Funct; 2010 Mar; 214(2-3):89-90. PubMed ID: 20169361
    [No Abstract]   [Full Text] [Related]  

  • 4. Neurodegenerative disease in 2015: Targeting tauopathies for therapeutic translation.
    Rojas JC; Boxer AL
    Nat Rev Neurol; 2016 Feb; 12(2):74-6. PubMed ID: 26794651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repression of tau hyperphosphorylation by chronic endurance exercise in aged transgenic mouse model of tauopathies.
    Leem YH; Lim HJ; Shim SB; Cho JY; Kim BS; Han PL
    J Neurosci Res; 2009 Aug; 87(11):2561-70. PubMed ID: 19360903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raphé tauopathy alters serotonin metabolism and breathing activity in terminal Tau.P301L mice: possible implications for tauopathies and Alzheimer's disease.
    Menuet C; Borghgraef P; Matarazzo V; Gielis L; Lajard AM; Voituron N; Gestreau C; Dutschmann M; Van Leuven F; Hilaire G
    Respir Physiol Neurobiol; 2011 Sep; 178(2):290-303. PubMed ID: 21763469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human misfolded truncated tau protein promotes activation of microglia and leukocyte infiltration in the transgenic rat model of tauopathy.
    Zilka N; Stozicka Z; Kovac A; Pilipcinec E; Bugos O; Novak M
    J Neuroimmunol; 2009 Apr; 209(1-2):16-25. PubMed ID: 19232747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invited review: Animal models of tauopathies and their implications for research/translation into the clinic.
    Dujardin S; Colin M; Buée L
    Neuropathol Appl Neurobiol; 2015 Feb; 41(1):59-80. PubMed ID: 25428793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippocampal tauopathy in tau transgenic mice coincides with impaired hippocampus-dependent learning and memory, and attenuated late-phase long-term depression of synaptic transmission.
    Van der Jeugd A; Ahmed T; Burnouf S; Belarbi K; Hamdame M; Grosjean ME; Humez S; Balschun D; Blum D; Buée L; D'Hooge R
    Neurobiol Learn Mem; 2011 Mar; 95(3):296-304. PubMed ID: 21167950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and survival of 3R and 4R tauopathies presenting as behavioral variant frontotemporal dementia.
    Hu WT; Parisi JE; Knopman DS; Boeve BF; Dickson DW; Ahlskog JE; Petersen RC; Josephs KA
    Alzheimer Dis Assoc Disord; 2007; 21(4):S39-43. PubMed ID: 18090422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stress-induced activation of the sympathoadrenal system is determined by genetic background in rat models of tauopathy.
    Lejavova K; Ondicova K; Horvathova L; Hegedusova N; Cubinkova V; Vargovic P; Manz G; Filipcik P; Mravec B; Novak M; Kvetnansky R
    J Alzheimers Dis; 2015; 43(4):1157-61. PubMed ID: 25147110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau-targeting passive immunization modulates aspects of pathology in tau transgenic mice.
    Ittner A; Bertz J; Suh LS; Stevens CH; Götz J; Ittner LM
    J Neurochem; 2015 Jan; 132(1):135-45. PubMed ID: 25041093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurodegenerative tauopathy in the worm.
    Goedert M
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9653-5. PubMed ID: 12913116
    [No Abstract]   [Full Text] [Related]  

  • 15. Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies.
    Zilka N; Korenova M; Novak M
    Acta Neuropathol; 2009 Jul; 118(1):71-86. PubMed ID: 19238406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of a truncated tau protein induces oxidative stress in a rodent model of tauopathy.
    Cente M; Filipcik P; Pevalova M; Novak M
    Eur J Neurosci; 2006 Aug; 24(4):1085-90. PubMed ID: 16930434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load.
    Koson P; Zilka N; Kovac A; Kovacech B; Korenova M; Filipcik P; Novak M
    Eur J Neurosci; 2008 Jul; 28(2):239-46. PubMed ID: 18702695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neuropathological spectrum of neurodegenerative tauopathies.
    Tolnay M; Probst A
    IUBMB Life; 2003 Jun; 55(6):299-305. PubMed ID: 12938731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intercellular transfer of tau aggregates and spreading of tau pathology: Implications for therapeutic strategies.
    Clavaguera F; Grueninger F; Tolnay M
    Neuropharmacology; 2014 Jan; 76 Pt A():9-15. PubMed ID: 24050961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Passive Tau immunotherapy for prevention of Tau pathology progression].
    Ozmen L; Collin L
    Med Sci (Paris); 2015 Feb; 31(2):132-4. PubMed ID: 25744257
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.